Liver disease, a major cause of global mortality, has been associated with dysbiosis of the intestinal microbiota (bacteria, fungi, viruses, and other microbes). Studies have associated changes in gut bacteria with pathogenesis and severity of liver disease, but the contributions of the mycobiome (the fungal populations of the gut) to health and disease have not been well studied. We review recent findings of alterations in the composition of the mycobiota in patients with liver disease and discuss the mechanisms by which these might affect pathogenesis and disease progression. Strategies to manipulate the gut mycobiota might be developed to treat or prevent liver disease.
Keywords: alcohol-associated liver disease; cirrhosis; fungi; fungi-bacterial interaction; immune response; non-alcoholic fatty liver disease; yeast.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.